Acorda therapeutics posts q4 earnings per share $1.38

Acorda therapeutics provides business update and reports fourth quarter and full year 2019 financial results.q4 gaap earnings per share $1.38.q4 non-gaap loss per share $0.15.q4 earnings per share estimate $-0.41 -- refinitiv ibes data.acorda therapeutics - total product net revenue for full year 2020 is expected to be $120 - $150 million with total revenue expected to be $130 - $160 million.fy2020 revenue view $149.2 million -- refinitiv ibes data.
ACOR Ratings Summary
ACOR Quant Ranking